Section on Translational Medicines ‘Ecosystem’

Participating journal

Articles

1. The need for clear medical data ownership laws

   • David C. Klonoff
   • Agatha F. Scheideman
   • Lutz Heinemann

   Commentary Open access 03 January 2026 Article: 5

2. Long non-coding RNAs in osteosarcoma: multifaceted regulators of malignancy and therapeutic resistance

   • Pei Liu
   • Weiwei Wang
   • Yongqiang Sun

   Review Open access 23 December 2025 Article: 107

3. Comparative analysis of burden of topmost disorders requiring rehabilitation services: a systematic review and meta-analysis

   • Echezona Nelson Dominic Ekechukwu
   • Olive Udunma Chijioke
   • Mayowa Ojo Owolabi

   Research Open access 25 September 2025 Article: 1015

4. Bridging the prevention gap: funding distribution and methodological shifts in prevention-focused biomedical research under EU framework programmes

   • Francesca Pistollato
   • Fabia Furtmann
   • Helder Constantino

   Research Open access 24 September 2025 Article: 1006

5. Facilitating consumer partnerships in health research

   • Raluca Ghebosu
   • Leonie Young
   • Joy Wolfram

   Research Open access 22 September 2025 Article: 990

6. Who should be included in first-in-human trials? A systematic review of reasons

   • Lieke van Kempen
   • Martine C. de Vries
   • Nienke de Graeff

   Review Open access 11 June 2025 Article: 649

7. Chinese physician-scientists: dual-role professionals emerging amid institutional constraints

   • Zequn Li
   • Yanbing Zhou

   Letter to the Editor Open access 08 May 2025 Article: 522

8. Get this thing out of my body! Factors determining consent for translational oncology research: a qualitative research

   • Desprès Caroline
   • Mamzer Marie-France

   Research Open access 21 May 2023 Article: 336

9. Good practice in medicine and biology: scientific integrity needs global bioethics

   • Henri-Corto Stoeklé
   • Achille Ivasilevitch
   • Christian Hervé

   Commentary Open access 20 January 2023 Article: 37

10. Improving public cancer care by implementing precision medicine in Norway: IMPRESS-Norway

    • Åslaug Helland
    • Hege G. Russnes
    • Sigbjørn Smeland

    Protocol Open access 14 May 2022 Article: 225

11. Recommendations for addressing the translational gap between experimental and clinical research on amyloid diseases

    • Miriam Solomon
    • Vito Foderà
    • Vittorio Bellotti

    Meeting report Open access 13 May 2022 Article: 213

12. From biobank and data silos into a data commons: convergence to support translational medicine

    • Rebecca Asiimwe
    • Stephanie Lam
    • Aline Talhouk

    Methodology Open access 04 December 2021 Article: 493

13. Barriers to translational research in Windsor Ontario: a survey of clinical care providers and health researchers

    • Justin B. Senecal
    • Karen Metcalfe
    • Lisa A. Porter

    Research Open access 27 November 2021 Article: 479

14. A large National Institute for Health Research (NIHR) Biomedical Research Centre facilitates impactful cross-disciplinary and collaborative translational research publications and research collaboration networks: a bibliometric evaluation study

    • Vasiliki Kiparoglou
    • Laurence A. Brown
    • Syed Ghulam Sarwar Shah

    Research Open access 27 November 2021 Article: 483

15. Childbearing vs. clinical trial participation: is it one or the other?

    • Sarah J. Hernandez
    • Lindsay A. Hohsfield

    Commentary Open access 15 June 2021 Article: 260

16. Collaborative relationships in translational medical research among Chinese clinicians: an internet-based cross-sectional survey

    • Meina Li
    • Bin Lian
    • Lulu Zhang

    Research Open access 05 June 2021 Article: 247

17. Translational precision medicine: an industry perspective

    • Dominik Hartl
    • Valeria de Luca
    • Adrian Roth

    Review Open access 05 June 2021 Article: 245

18. Translational research in Uganda: linking basic science to bedside medicine in a resource limited setting

    • Richard Kwizera
    • Emmanuel Mande
    • David B. Meya

    Review Open access 16 February 2021 Article: 76

19. Why scientists, academic institutions, and investors fail in bringing more products to the bedside: the Active Compass model for overcoming the innovation paradox

    • Yaron Ilan

    Review Open access 04 February 2021 Article: 55

20. The generic Informed Consent Service gICS^®: implementation and benefits of a modular consent software tool to master the challenge of electronic consent management in research

    • Henriette Rau
    • Lars Geidel
    • Wolfgang Hoffmann

    Research Open access 29 July 2020 Article: 287

21. “Right-to-Try” experimental drugs: an overview

    • Vijay Mahant

    Review Open access 23 June 2020 Article: 253

22. How personalised medicine will transform healthcare by 2030: the ICPerMed vision

    • Astrid M. Vicente
    • Wolfgang Ballensiefen
    • Jan-Ingvar Jönsson

    Commentary Open access 28 April 2020 Article: 180

23. Translational medicines “Ecosystem”

    • Vijay Mahant

    Editorial Open access 06 April 2020 Article: 158